3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
24
Neoplasm Metastasis
6
Colonic Neoplasms
6
Stomach Neoplasms
5
Rectal Neoplasms
5
Carcinoma, Hepatocellular
4
Cholangiocarcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Biliary Tract Neoplasms
3
Adenocarcinoma Of Esophagus
3
Unresectable Metastatic Colorectal Cancer
2
Recurrence
2
Neoplastic Cells, Circulating
2
Neoplasms
2
Gastrointestinal Neoplasms
2
Adenocarcinoma
2
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Ovarian Neoplasms
1
Oligometastatic Gastric Adenocarcinoma
1
Neoplasms, Second Primary
1
Neoplasm, Residual
1
Margins of Excision
1
Lung Neoplasms
1
Locally-advanced Rectal Cancer
1
Locally Advanced Colorectal Carcinoma
1
Hyperthermia
1
Gastroesophageal Junction Adenocarcinoma
1
Gastroesophageal Adenocarcinoma
1
Gallbladder Neoplasms
1
Interventions
Oxaliplatin
10
pembrolizumab
8
Fluorouracil
8
Leucovorin
7
Paclitaxel
5
Gemcitabine
5
Docetaxel
5
Capecitabine
5
Cyclophosphamide
4
Blood Specimen Collection
4
zolbetuximab
3
fludarabine
3
cemiplimab
3
Trastuzumab
3
Taxes
3
Ramucirumab
3
Radiotherapy
3
Radiosurgery
3
Irinotecan
3
trastuzumab deruxtecan
2
enzalutamide
2
durvalumab
2
darolutamide
2
Standard of Care
2
Nivolumab
2
Folfox protocol
2
Dexamethasone
2
Cisplatin
2
130-nm albumin-bound paclitaxel
2
tucatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Adenocarcinoma
×
Folfox protocol
×
Clear all
NCT06846346
2026-04-28
GRACIE
UNICANCER
Phase 2
Recruiting
88 enrolled
NCT05476796
2024-10-24
LOGICAN
UNICANCER
Phase 2
Recruiting
118 enrolled